Don't be greedy! And I don't think Dr. M should be greedy, either. If there's a buyout offer, and its reasonable, I think he'll take it. The talks of Dr. M caring about desiring to be the "CEO of the Apple of Biotechs" or making himself a billionaire don't make sense to me. Dr. Missling is in this to get a successful AD drug to market and to make $$$. If BP offers a buyout because the data is good, his goals will still be met. He's worked in BO for too long to pass up on an opportunity to reduce risk by having someone else find the rest of the trials. But, given our deep pipeline, it seems more likely that a partnership is likely.
Market Data 
Markets 
AI
